Congressmembers Langworthy, Schrier Introduce Bipartisan Bill to Lower Prescription Drug Costs by Expanding Access to Biosimilars
Health-System Pharmacists (ASHP), and Americans for Prosperity (AFP). “Biosimilars represent a significant and growing proportion … help you enact this bill swiftly.” -- Americans for Prosperity